PURA Confirms CBD Beverage Order From Distributor For Multi-Billion Euro Retail Grocery Chain Anticipated To Close This Week
September 25 2019 - 2:51PM
InvestorsHub NewsWire
DALLAS, TX -- September 25, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (PURA)
today announced that the company confirmed that it expects to close
its first major order for EVERx CBD Sports Water in Europe later
this week in response to the company’s European marketing campaign
that kicked off last week at Arnold Schwarzenegger’s Arnold Sports
Festival Europe in Barcelona. EVERx today is the leading CBD
infused sports nutrition beverage with over $1 million in sales in
2018 and over $1 million in sales in the first six months of 2019
and targeting $4 million in sales by 2019-year end. The EVERx
CBD Sports Water order anticipated later this week is expected to
be announced as part of a series of PURA Corporate Updates taking
place this week.
All New Comprehensive PURA Research
Analyst Report
Earlier today PURA announced an all new
research analyst report from Goldman Small Cap Research.
Goldman originally published an extensive research report on PURA
and the cannabis infused beverage industry one year ago followed by
three subsequent updates to the original report. The most
recent update was published last week in conjunction with a CBD
Beverage Industry Survey conducted to primarily review new CBD
beverage products being introduced by PURA. The recent
update confirmed Goldman’s original research recommendations.
With the magnitude of changes within the overall CBD Beverage
Industry over the last year combined with the substantial growth
and evolution of PURA’s business, a new comprehensive study of the
industry and the company was warranted. The report includes new and upgraded investment
recommendations.
EVERx CBD Sports Water is available for
purchase on line at www.USMJ.com
hosted by PURA’s partner North
American Cannabis Holdings, Inc. (USOTC:
USMJ).
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024